Abatacept

Description

Abatacept is a fusion protein that consists of the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) linked to a modified Fc portion of human immunoglobulin G1 (IgG1). Abatacept selectively modulates a key costimulatory signal required for full activation of T lymphocytes expressing CD28.

Medicine classification

ATC Code
Title
Class
Abatacept
L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants

Medicines

Drug
Countries

Australia Austria Canada Cyprus France

Product monographs

Unique Ingredient Identifier (UNII)

7D0YB67S97 - ABATACEPT

CAS Registry Number

332348-12-6 - abatacept

SNOMED-CT

421777009 - Abatacept (substance)